A new study has found for female participants with migraine that as estrogen levels fluctuate their levels of the protein calcitonin gene-related peptide (CGRP) that plays a key role in starting the migraine process also fluctuates.
As estrogen levels fluctuate, a new study has found for female participants with migraine, their levels of the protein calcitonin gene-related peptide (CGRP) that plays a key role in starting the migraine process also fluctuate. The study is published in the online issue of Neurology, the me
New York City [US], April 21 (ANI): A new study discovered how pain is signalled from within Schwann cells and finds several ways to block this signalling, providing potential targets for new migraine treatments.